Brain gamma-aminobutyric acid deficiency in dialysis encephalopathy.
We measured levels of gamma-aminobutyric acid (GABA) in the CSF and in the autopsied brain of patients with dialysis encephalopathy. GABA concentrations were low in the CSF of three of five living patients. Mean GABA content was reduced by 30 to 50% in five brain regions (frontal, occipital, and cerebellar cortex, caudate nucleus, and medial dorsal thalamus) in five fatal cases. GABA content was normal in brain regions where GABA is characteristically reduced in Huntington's disease. Choline acetyltransferase activity was diminished (by 25 to 35%) in cerebral cortex of the dialysis encephalopathy patients.
D000328:Adult; D000535:Aluminum / Q000378:metabolism; D001923:Brain Chemistry; D001927:Brain Diseases / Q000134:cerebrospinal fluid / Q000209:etiology / Q000378:metabolism*; D002540:Cerebral Cortex / Q000201:enzymology; D002795:Choline O-Acetyltransferase / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D005680:gamma-Aminobutyric Acid / Q000134:cerebrospinal fluid / Q000172:deficiency*
D005680:gamma-Aminobutyric Acid; D000535:Aluminum; D002795:Choline O-Acetyltransferase